The Dark Side of 5α-Reductase Inhibitors' Ther... [Korean J Urol. 2014] - Pub... - 0 views
-
Nathan Goodyear on 24 Jun 14Nice review of the inherent risks associated with 5alpha-reductase inhibition therapy.
Dr. Goodyear is passionate about all things wellness. In particular, Dr. Goodyear is the Medical Director at Brio-Medical in Arizona to take on one of the greatest obstacles to long-term wellness in the Western hemisphere--cancer. In addition, Dr. Goodyear is the Chairman of the Scientific Medical Advisory Board of the Vitamin C International Consortium Institute (VCICI)